1 results match your criteria: "From the Division of Pathology and Data Analytics University of Leeds[Affiliation]"

Context.—: The current melanoma staging system does not account for 26% of the variance seen in melanoma-specific survival, therefore our ability to predict patient outcome is not fully elucidated. Morphology may be of greater significance than in other solid tumors, with Breslow thickness remaining the strongest prognostic indicator despite being subject to high levels of interobserver variation.

View Article and Find Full Text PDF